This HTML5 document contains 159 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n9http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q30381713
rdf:type
wikibase:Item
schema:description
2009年论文 2009 nî lūn-bûn tieteellinen artikkeli научная статья 2009년 논문 2009年论文 наукова стаття, опублікована в жовтні 2009 ২০০৯-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ مقالة علمية (نشرت في 14-10-2009) vědecký článek artículu científicu espublizáu en 2009 mokslinis straipsnis article scientific artikulong pang-agham articol științific 2009 թվականի հոտեմբերին հրատարակված գիտական հոդված 2009年論文 2009年論文 bilimsel makale vitskapeleg artikkel επιστημονικό άρθρο vedecký článok מאמר מדעי scienca artikolo научна статия научни чланак article científic سائنسی مضمون บทความทางวิทยาศาสตร์ мақолаи илмӣ 2009年论文 tudományos cikk 2009年論文 artykuł naukowy vitenskapelig artikkel vetenskaplig artikel artikull shkencor სამეცნიერო სტატია мақолаи илмӣ 2009年论文 artículo científico publicado en 2009 2009年論文 artigo científico (publicado na 2009) scientific article articolo scientifico artigo científico 2009年论文 2009年の論文 مقالهٔ علمی artigo científico (publicado na 2009) 2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած научни чланак wissenschaftlicher Artikel teaduslik artikkel naučni članak 2009年论文 2009年論文 videnskabelig artikel (udgivet 2009) article scientifique (publié 2009) bài báo khoa học wetenschappelijk artikel
p:P577
wds:Q30381713-76D51AF8-13D5-45FF-BE42-1098EB8CAFED
wdt:P577
2009-10-14T00:00:00Z
p:P407
wds:Q30381713-CD47C845-9312-4257-A6BD-D102F2C315B2
wdt:P407
wd:Q1860
p:P2860
wds:Q30381713-EC397456-F08A-4B3D-9492-2AA11CB71B2D wds:Q30381713-DC8802E3-C53B-4B98-BB03-56B66D47DC0D wds:Q30381713-E1B9FE6C-8CBF-4708-B7D6-178FB807D65A wds:Q30381713-C95F0804-7C1A-4247-9D05-37E3500DC3E3 wds:Q30381713-CA93AEBE-2880-4363-8665-6F65D9C7420C wds:Q30381713-A21FADE4-F677-480C-97AD-A3093A6753D7 wds:Q30381713-A4D35CA8-8485-467C-B88B-2973E4C30CD7 wds:Q30381713-AB4BB1E1-6D0D-4F4F-A264-DE6218289404 wds:Q30381713-B26E840C-D288-40CD-A85C-9799F538ABC8 wds:Q30381713-996EB518-AFCD-4DFB-B09F-C9E160545CAC wds:Q30381713-9B552A4F-D69B-4809-997E-3B7779522C2D wds:Q30381713-77CD8CA8-CDCA-4060-B5D5-07908598835A wds:Q30381713-5E378DA4-7DB0-4857-95AA-EC5897B67203 wds:Q30381713-5BA43096-DF9C-4641-9536-2F8EAF1C3340 wds:Q30381713-5DE0D6F1-F27B-4F47-BFB7-A43C6D52F48F wds:Q30381713-2D96A6FB-C40F-4B13-9780-0A1F57858510 wds:Q30381713-34EA816E-3EC1-4695-B929-50AA0F597DE1 wds:Q30381713-1D7F0B0E-E54D-443B-9A19-16B1651EB61A wds:Q30381713-2108E6A0-B321-4063-8123-DF1DED15E2A5
wdt:P2860
wd:Q28264923 wd:Q55041754 wd:Q30374764 wd:Q30370214 wd:Q30371327 wd:Q37510254 wd:Q30379899 wd:Q30368814 wd:Q30363500 wd:Q30354497 wd:Q30229190 wd:Q30375975 wd:Q30328341 wd:Q38392346 wd:Q21144344 wd:Q30372127 wd:Q46325181 wd:Q40096549 wd:Q37266009
p:P2093
wds:Q30381713-63F7A399-703A-4C36-AC7D-A3C95CAA2572 wds:Q30381713-C463FD16-1003-45FD-AF88-E764B0E43808 wds:Q30381713-2A32ABDC-B3FE-498C-901A-2E6E16A6BB49 wds:Q30381713-38A451EF-4E4A-43B8-912B-44F661955614 wds:Q30381713-13C4C834-3C73-4BBA-9194-A35991D7692A wds:Q30381713-0239F077-F5ED-4C1D-B126-8376132C433C wds:Q30381713-987BDDD6-D56A-4DEC-BF60-02FA76D003AF
wdt:P2093
Robbert van der Most Emmanuel Hanon Fien De Boever Cathy Maes Sheron Forgus Marcelle Van Mechelen Isabel Leroux-Roels
rdfs:label
Priming with AS03 A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: an open non-randomised extension of a double-blind randomised primary study. Priming with AS03 A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: an open non-randomised extension of a double-blind randomised primary study. Priming with AS03 A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: an open non-randomised extension of a double-blind randomised primary study.
skos:prefLabel
Priming with AS03 A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: an open non-randomised extension of a double-blind randomised primary study. Priming with AS03 A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: an open non-randomised extension of a double-blind randomised primary study. Priming with AS03 A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: an open non-randomised extension of a double-blind randomised primary study.
schema:name
Priming with AS03 A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: an open non-randomised extension of a double-blind randomised primary study. Priming with AS03 A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: an open non-randomised extension of a double-blind randomised primary study. Priming with AS03 A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: an open non-randomised extension of a double-blind randomised primary study.
p:P50
wds:Q30381713-4C802EB6-1766-4F0F-BB29-45CC49BBDC1A wds:Q30381713-5AD36302-0A89-46C3-814B-E058553DD795 wds:Q30381713-7C77C9EE-B061-4E8F-BDF0-8D87B495B3EE wds:Q30381713-9798B8D6-7C5F-45E2-A14E-DCBCE14A4690
wdt:P50
wd:Q91747664 wd:Q104748926 wd:Q104745044 wd:Q45380570
p:P1476
wds:Q30381713-69B5AB16-2A92-44BE-AC6F-1D9D0898E312
wdt:P1476
Priming with AS03 A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: an open non-randomised extension of a double-blind randomised primary study.
p:P304
wds:Q30381713-E2654EFB-A61A-4E5E-8F5A-FE660322F448
wdt:P304
849-857
p:P31
wds:Q30381713-05A22A10-FA07-4904-A212-7674FE59F9BE
wdt:P31
wd:Q13442814
p:P921
wds:Q30381713-D11AF574-64E0-425F-8E80-F4B20EA1C5D2 wds:Q30381713-252ABAC8-61AA-4D86-8FFB-532479A38BA8
wdt:P921
wd:Q383260 wd:Q134808
p:P698
wds:Q30381713-E36825AB-22CC-4FC6-B006-5798C371324D
wdtn:P698
n12:19835828
wdt:P698
19835828
p:P1433
wds:Q30381713-B934ACA5-924E-4292-B625-2194E755F95D
wdt:P1433
wd:Q7907941
p:P433
wds:Q30381713-4AFCAB20-8485-435B-B0CD-4D9C4AE13184
p:P478
wds:Q30381713-8034F538-9229-44E6-9C76-4ADFC8134AE9
wdt:P433
3
wdt:P478
28
p:P356
wds:Q30381713-FC4171B2-1307-4485-9E10-AD48C2DF5551
wdtn:P356
n9:J.VACCINE.2009.10.017
wdt:P356
10.1016/J.VACCINE.2009.10.017
p:P5875
wds:Q30381713-95C8574D-61D4-4A43-B976-452A772EBC3E
wdt:P5875
38017023